Compare $AKTX vs $SYBX | Chartloom

Compare

$AKTX vs $SYBX

Akari Therapeutics PLC · Synlogic Inc

AKTX

Akari Therapeutics PLC

SYBX

Synlogic Inc

Compare $AKTX vs $SYBX

Comparing Akari Therapeutics PLC and Synlogic Inc

AKTXAkari Therapeutics PLC

SYBXSynlogic Inc

AKTXAkari Therapeutics PLC

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-24.4%

52W performance

-78.5%

FCF yield

-63.0%

SYBXSynlogic Inc

Market cap

$13M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-6.0%

52W performance

-24.7%

FCF yield

-28.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AKTX

SYBX

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

SYBX

Synlogic Inc

Market Cap

AKTX$17M

SYBX$13M

Enterprise Value

AKTX$10M

SYBX$292K

Price

AKTX$8.77

SYBX$1.10

P/E Ratio

AKTXN/A

SYBXN/A

P/S Ratio

AKTX0.00x

SYBX4.20x

EV/Sales

AKTX0.00x

SYBX0.09x

EV/EBITDA

AKTX0.00x

SYBX0.00x

P/B Ratio

AKTX0.83x

SYBX1.12x

P/FCF Ratio

AKTXN/A

SYBXN/A

EV/FCF

AKTX-0.94x

SYBX-0.08x

PEG Ratio

AKTXN/A

SYBXN/A

Forward P/E (NTM)

AKTXN/A

SYBXN/A

Forward P/S (NTM)

AKTXN/A

SYBXN/A

Revenue (TTM)

AKTX$0

SYBX$0

Revenue Growth (YoY)

AKTXN/A

SYBXN/A

Forward Rev Growth

AKTX137.9%

SYBX0.0%

Gross Margin (TTM)

AKTX0.0%

SYBX0.0%

Operating Margin (TTM)

AKTX0.0%

SYBX0.0%

EBITDA Margin (TTM)

AKTX0.0%

SYBX0.0%

Net Margin (TTM)

AKTX0.0%

SYBX0.0%

FCF Margin (TTM)

AKTXN/A

SYBXN/A

Net Income (TTM)

AKTX$-31M

SYBX$-655K

FCF (TTM)

AKTX$-11M

SYBX$-4M

EPS (TTM)

AKTX-$0.40

SYBX-$0.05

ROE (TTM)

AKTX-14745.0%

SYBX-560.0%

ROA (TTM)

AKTX-7470.0%

SYBX-436.0%

ROIC (TTM)

AKTX-14027.0%

SYBX-560.0%

Cash

AKTX$8M

SYBX$13M

Debt

AKTX$693K

SYBX$0

Net Cash/Debt

AKTX$7M

SYBX$13M

Current Ratio (TTM)

AKTX0.60x

SYBX9.19x

Quick Ratio (TTM)

AKTX0.56x

SYBX9.05x

Debt/Equity (TTM)

AKTX0.04x

SYBX0.00x

Debt/Assets (TTM)

AKTX0.0%

SYBX0.0%

Interest Coverage (TTM)

AKTXN/A

SYBXN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

SYBX0.00x

Beta

AKTX1.48

SYBX0.87

52W Performance

AKTX-78.5%

SYBX-24.7%

YTD Performance

AKTX-24.4%

SYBX-6.0%

% from 52W High

AKTX-79.5%

SYBX-41.2%

% from 52W Low

AKTX190.4%

SYBX103.7%

Asset Turnover (TTM)

AKTX0.00x

SYBX0.05x

FCF Yield (TTM)

AKTX-63.0%

SYBX-28.5%

Earnings Yield (TTM)

AKTX-181.3%

SYBX-4.9%

Dividend Yield (TTM)

AKTXN/A

SYBXN/A

Rule of 40

AKTX0.0

SYBX0.0

EV/GP/RG

AKTXN/A

SYBXN/A

Ticker research

View AKTX research View SYBX research

Metric	AKTX Akari Therapeutics PLC	SYBX Synlogic Inc
Market & Valuation
Market Cap	$17M	$13M
Enterprise Value	$10M	$292K
Price	$8.77	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.20x
EV/Sales	0.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-655K
FCF (TTM)	$-11M	$-4M
EPS (TTM)	-$0.40	-$0.05
ROE (TTM)	-14745.0%	-560.0%
ROA (TTM)	-7470.0%	-436.0%
ROIC (TTM)	-14027.0%	-560.0%
Financial Health
Cash	$8M	$13M
Debt	$693K	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	0.60x	9.19x
Quick Ratio (TTM)	0.56x	9.05x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.87
52W Performance	-78.5%	-24.7%
YTD Performance	-24.4%	-6.0%
% from 52W High	-79.5%	-41.2%
% from 52W Low	190.4%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-63.0%	-28.5%
Earnings Yield (TTM)	-181.3%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View SYBX research

Valuation

P/S Ratio

AKTX

0.00x

SYBX

4.20x

EV/FCF

AKTX

-0.94x

SYBX

-0.08x

Growth & revenue

Forward Revenue Growth

AKTX

137.9%

SYBX

0.0%

Profitability & performance

Gross Margin

AKTX

0.0%

SYBX

0.0%

ROE

SYBX

-560.0%

AKTX

-14745.0%

FCF Yield %

SYBX

-28.5%

AKTX

-63.0%

52-Week Performance

SYBX

-24.7%

AKTX

-78.5%

Detailed metrics comparison

AKTX

Akari Therapeutics PLC

SYBX

Synlogic Inc

Market Cap

AKTX$17M

SYBX$13M

Enterprise Value

AKTX$10M

SYBX$292K

Price

AKTX$8.77

SYBX$1.10

P/E Ratio

AKTXN/A

SYBXN/A

P/S Ratio

AKTX0.00x

SYBX4.20x

EV/Sales

AKTX0.00x

SYBX0.09x

EV/EBITDA

AKTX0.00x

SYBX0.00x

P/B Ratio

AKTX0.83x

SYBX1.12x

P/FCF Ratio

AKTXN/A

SYBXN/A

EV/FCF

AKTX-0.94x

SYBX-0.08x

PEG Ratio

AKTXN/A

SYBXN/A

Forward P/E (NTM)

AKTXN/A

SYBXN/A

Forward P/S (NTM)

AKTXN/A

SYBXN/A

Revenue (TTM)

AKTX$0

SYBX$0

Revenue Growth (YoY)

AKTXN/A

SYBXN/A

Forward Rev Growth

AKTX137.9%

SYBX0.0%

Gross Margin (TTM)

AKTX0.0%

SYBX0.0%

Operating Margin (TTM)

AKTX0.0%

SYBX0.0%

EBITDA Margin (TTM)

AKTX0.0%

SYBX0.0%

Net Margin (TTM)

AKTX0.0%

SYBX0.0%

FCF Margin (TTM)

AKTXN/A

SYBXN/A

Net Income (TTM)

AKTX$-31M

SYBX$-655K

FCF (TTM)

AKTX$-11M

SYBX$-4M

EPS (TTM)

AKTX-$0.40

SYBX-$0.05

ROE (TTM)

AKTX-14745.0%

SYBX-560.0%

ROA (TTM)

AKTX-7470.0%

SYBX-436.0%

ROIC (TTM)

AKTX-14027.0%

SYBX-560.0%

Cash

AKTX$8M

SYBX$13M

Debt

AKTX$693K

SYBX$0

Net Cash/Debt

AKTX$7M

SYBX$13M

Current Ratio (TTM)

AKTX0.60x

SYBX9.19x

Quick Ratio (TTM)

AKTX0.56x

SYBX9.05x

Debt/Equity (TTM)

AKTX0.04x

SYBX0.00x

Debt/Assets (TTM)

AKTX0.0%

SYBX0.0%

Interest Coverage (TTM)

AKTXN/A

SYBXN/A

Net Debt/EBITDA (TTM)

AKTX0.00x

SYBX0.00x

Beta

AKTX1.48

SYBX0.87

52W Performance

AKTX-78.5%

SYBX-24.7%

YTD Performance

AKTX-24.4%

SYBX-6.0%

% from 52W High

AKTX-79.5%

SYBX-41.2%

% from 52W Low

AKTX190.4%

SYBX103.7%

Asset Turnover (TTM)

AKTX0.00x

SYBX0.05x

FCF Yield (TTM)

AKTX-63.0%

SYBX-28.5%

Earnings Yield (TTM)

AKTX-181.3%

SYBX-4.9%

Dividend Yield (TTM)

AKTXN/A

SYBXN/A

Rule of 40

AKTX0.0

SYBX0.0

EV/GP/RG

AKTXN/A

SYBXN/A

Ticker research

View AKTX research View SYBX research

Metric	AKTX Akari Therapeutics PLC	SYBX Synlogic Inc
Market & Valuation
Market Cap	$17M	$13M
Enterprise Value	$10M	$292K
Price	$8.77	$1.10
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	4.20x
EV/Sales	0.00x	0.09x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.83x	1.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-0.08x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	137.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-31M	$-655K
FCF (TTM)	$-11M	$-4M
EPS (TTM)	-$0.40	-$0.05
ROE (TTM)	-14745.0%	-560.0%
ROA (TTM)	-7470.0%	-436.0%
ROIC (TTM)	-14027.0%	-560.0%
Financial Health
Cash	$8M	$13M
Debt	$693K	$0
Net Cash/Debt	$7M	$13M
Current Ratio (TTM)	0.60x	9.19x
Quick Ratio (TTM)	0.56x	9.05x
Debt/Equity (TTM)	0.04x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.87
52W Performance	-78.5%	-24.7%
YTD Performance	-24.4%	-6.0%
% from 52W High	-79.5%	-41.2%
% from 52W Low	190.4%	103.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.05x
FCF Yield (TTM)	-63.0%	-28.5%
Earnings Yield (TTM)	-181.3%	-4.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AKTX research	View SYBX research